Mereo BioPharma (MREO) Treasury Shares (2018 - 2026)
Mereo BioPharma (MREO) posted quarterly Treasury Shares of $1.2 million for Q4 2023, down 0.88% year-over-year from $1.2 million in Q4 2022, and down 7.1% quarter-over-quarter from $1.3 million in Q2 2023.
Mereo BioPharma (MREO) Treasury Shares (2018 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Treasury Shares for 6 consecutive years, with $1.2 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Treasury Shares fell 0.88% year-over-year to $1.2 million; the TTM figure through Dec 2023 stood at $1.2 million (down 0.88% YoY), while the FY2023 annual figure was $1.2 million, down 7.87% from the prior year.
- Treasury Shares fell to $1.2 million in Q4 2023 per MREO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Treasury Shares topped out at $1.6 million in Q1 2026 and bottomed at $408230.7 in Q4 2022.
- Historically, Treasury Shares has averaged $981005.5 across 5 years, with a median of $979608.0 in 2025.
- Annual changes were most pronounced in 2019 — Treasury Shares surged 324.74% — and 2022, when it decreased 19.25%.
- Mereo BioPharma's Treasury Shares stood at $1.7 million in 2019, then increased by 2.7% to $1.7 million in 2020, then fell by 10.82% to $1.5 million in 2021, then slipped by 19.25% to $1.2 million in 2022, then declined by 0.88% to $1.2 million in 2023.
- Business Quant data shows MREO's Treasury Shares at $1.2 million in Q4 2023, $1.3 million in Q2 2023, and $1.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 979,608.00 |
| Dec 31, 2025 | 979,608.00 |
| Sep 30, 2025 | 979,608.00 |
| Sep 30, 2025 | 979,608.00 |
| Jun 30, 2025 | 979,608.00 |
| Jun 30, 2025 | 979,608.00 |
| Mar 31, 2025 | 979,608.00 |
| Mar 31, 2025 | 979,608.00 |
| Dec 31, 2024 | 855,375.00 |
| Dec 31, 2024 | 855,375.00 |
| Sep 30, 2024 | 855,375.00 |
| Sep 30, 2024 | 855,375.00 |
| Jun 30, 2024 | 855,375.00 |
| Jun 30, 2024 | 855,375.00 |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |